Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Lessons Learned From Lockdown: Viral Hepatitis–Related Liver Disease in the COVID-19 Era

Robert G. Gish, MD
Released: January 10, 2022
Back Next


This Clinical Focus module will center on lessons learned on the interplay of COVID-19 and viral hepatitis–related liver disease. We will look at COVID-19 risk and outcomes in patients with chronic liver disease (CLD) and expert guidance on the management of such patients. Finally, we will discuss vaccine recommendations for our patients with immune suppression, and the lessons we have learned from managing liver disease and COVID-19 using telemedicine during the pandemic.

The slide thumbnails in this activity link to a complete PowerPoint slideset that can be found here or downloaded by clicking any of the thumbnails within the activity.

Clinical Care Options plans to measure the educational impact of this activity, and some questions will be asked twice: once before the discussion that informs the best choice and again after that specific discussion. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings